Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-06-28 |
Court | District Court, D. New Jersey | Date Terminated | 2020-01-05 |
Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
Patents | 8,809,307 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED
Details for BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-06-28 | 1 | Complaint | Plaintiffs”) for infringement of U.S. Patent No. 8,809,307 (the “’307 Patent”) by Defendant Glenmark Pharmaceuticals…for infringement of the ’307 Patent. This action arises under the Patent Laws of the United States, 35… THE PATENT-IN-SUIT 16. On August 19, 2014, the ’307 Patent entitled “Pharmaceutical…’307 Patent is attached as Exhibit 1.) 17. The named inventors of the ’307 Patent are …the term of the ’307 Patent, including any extension(s) granted by the U.S. Patent and Trademark Office | External link to document |
2020-01-05 | 14 | Dismissal, the term ‘“Patents-in-Suit” shall mean U.S. Patent No. 8,809,307 (“the °307 patent). 3. As used in…Glenmark stipulates that, until expiration of the Patents-in-Suit, Glenmark, including any of its Affiliates…, and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any Affiliate…parties in connection with any infringement of the Patents-in-Suit by any such third parties, unless and to…2019 6 January 2020 3:19-cv-14502 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |